Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.
Recursion Pharmaceuticals insiders completed 5 transactions: 3 stock sales totaling $268,602.34 and 2 stock awards with no reported value. All activity occurred between June and August 2026. Updated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results